Skip to content

4/AAccepted Jul 2, 8:00 PM ET

Cabell Christopher 4/A

IKTInhibikase Therapeutics, Inc.

Accepted (ET)

8:00 PM

Jul 2, 2025

Filed

Jul 2, 2025

Documents

1

Size

5.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.